Related Experiment Video
Updated: Jun 25, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
[Pharmacogenetics and tailored drug therapy]
Finn Cilius Nielsen1, Niels Borregaard
1Haematologisk Afdeling, Rigshospitalet, DK-2100 København Ø. borregaard@rh.regionh.dk
Ugeskrift for Laeger
|March 7, 2009
Summary
Pharmacogenetics, the study of genetic variations in drug metabolism, now includes using genetic alterations for tailored cancer and blood disorder treatments. This evolution enables personalized medicine approaches for improved patient outcomes.
Area of Science:
- Pharmacogenetics
- Genomics
- Translational Medicine
Context:
- Traditionally, pharmacogenetics focused on drug metabolism and environmental toxin interactions.
- The field has expanded to integrate genetic insights into disease development.
- This evolution is particularly relevant in oncology and hematology.
Purpose:
- To explore the broadened concept of pharmacogenetics.
- To highlight novel developments in pharmacogenetics.
- To discuss applications in oncology and hematology.
Summary:
- Pharmacogenetics traditionally studied genetic variations affecting drug and toxin metabolism.
- Its scope has widened to include leveraging genetic alterations for targeted disease treatments.
- Recent advancements focus on patient-tailored therapies in cancer and blood disorders.
Impact:
- Enables personalized medicine strategies.
- Facilitates targeted therapeutic interventions.
- Improves treatment efficacy in oncology and hematology.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...